Brain Targeted Drug Delivery System for Microglial Diseases: Recent Developments in Neuroinflammation and Neurodegeneration

Dilpreet      Singh; Sonima      Prasad

doi:10.2174/0115748855316358240427052701

Volume 20, Issue 2, 2025

Published on: 30 April, 2024

Page: [122 - 125] Pages: 4

DOI: 10.2174/0115748855316358240427052701

Keywords: Innovation, neuroinflammation, neurodegeneration, microglial diseases, drug delivery, precision, nanotechnology, therapy, central nervous system, immunomodulation.

« Previous Next »

Download Options

Rights & Permissions Print Cite

Current Drug Therapy

Title:Brain Targeted Drug Delivery System for Microglial Diseases: Recent Developments in Neuroinflammation and Neurodegeneration

Volume: 20 Issue: 2

Author(s): Dilpreet Singh*Sonima Prasad

Affiliation:

Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Chandigarh University, Gharuan, Mohali (140413), India
University Centre for Research and Development, Chandigarh University, Gharuan, Mohali (140413), India

Keywords: Innovation, neuroinflammation, neurodegeneration, microglial diseases, drug delivery, precision, nanotechnology, therapy, central nervous system, immunomodulation.

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Singh Dilpreet*, Prasad Sonima, Brain Targeted Drug Delivery System for Microglial Diseases: Recent Developments in Neuroinflammation and Neurodegeneration, Current Drug Therapy 2025; 20 (2) . https://dx.doi.org/10.2174/0115748855316358240427052701

DOI https://dx.doi.org/10.2174/0115748855316358240427052701	Print ISSN 1574-8855
Publisher Name Bentham Science Publisher	Online ISSN 2212-3903

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2025

Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)

The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more

Guest Editor(s): Dr. Ronald St-Louis